ITGB2 and neoplasm: VEGF has been shown to impair leukocyte‐endothelial interactions by reducing the adhesion molecules, ICAM‐1, VCAM‐1, and LFA‐1, in angiogenic vessels and hampering the infiltration of T‐effector cells into tumours.33, 34